S&P 500

5.460,48

-0,41%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Turnstone Biologics Corporation (TSBX)
Turnstone Biologics Corporation (TSBX) Notícias

TSBX

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:TSBX

1

Data	Hora	Fonte	Título	Código	Companhia
05/06/2024	18:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSBX	Turnstone Biologics Corporation
31/05/2024	17:23	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TSBX	Turnstone Biologics Corporation
13/05/2024	18:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TSBX	Turnstone Biologics Corporation
13/05/2024	18:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TSBX	Turnstone Biologics Corporation
13/05/2024	18:01	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
08/05/2024	10:00	GlobeNewswire Inc.	Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	NASDAQ:TSBX	Turnstone Biologics Corporation
16/04/2024	10:00	GlobeNewswire Inc.	Turnstone Biologics Appoints William Waddill to its Board of Directors	NASDAQ:TSBX	Turnstone Biologics Corporation
21/03/2024	18:06	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
21/02/2024	08:00	GlobeNewswire Inc.	Turnstone Biologics to Participate in Upcoming Investor Conferences	NASDAQ:TSBX	Turnstone Biologics Corporation
20/02/2024	19:00	GlobeNewswire Inc.	Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	NASDAQ:TSBX	Turnstone Biologics Corporation
27/11/2023	08:00	GlobeNewswire Inc.	Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:TSBX	Turnstone Biologics Corporation
09/11/2023	23:49	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
03/11/2023	07:00	GlobeNewswire Inc.	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:TSBX	Turnstone Biologics Corporation
30/10/2023	07:00	GlobeNewswire Inc.	Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber	NASDAQ:TSBX	Turnstone Biologics Corporation
17/10/2023	19:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
28/09/2023	07:00	GlobeNewswire Inc.	Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:TSBX	Turnstone Biologics Corporation
01/09/2023	18:57	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:TSBX	Turnstone Biologics Corporation
21/07/2023	03:15	GlobeNewswire Inc.	Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering	NASDAQ:TSBX	Turnstone Biologics Corporation